BRCA2 and posterior cortical atrophy: As expected, BRCA2 mutation carriers had the highest perceived risk of PCa, most frequently classifying risk as ‘slightly’ or ‘moderately’ increased, and controls most frequently classifying risk as the ‘same’ as the general population.